Biologics investors
5 investors that name Biologics among their sectors are recorded here: 3 private equity firms, 1 public fund and 1 venture capital firm. Stated investment stages run from pre-seed to buyout. Most are headquartered in Norway (2), the United Kingdom (1) and Sweden (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| CEPI (Coalition for Epidemic Preparedness Innovations) vaccines · biologics · epidemic and pandemic preparedness · RNA technology |
Direct investor | Public fund | Not stated | Oslo, Norway |
| EEP Advisers Limited life sciences · healthcare technology · biologics · cell and gene therapy |
Direct investor | Private equity | Seed – Growth | London, United Kingdom |
| Flerie Invest biotech · pharmaceutical · drug development · related devices |
Direct + LP | Venture capital | Pre-seed – Growth | Stockholm, Sweden |
| HealthpointCapital Management, LLC musculoskeletal healthcare · orthopedics · medical devices · biologics |
Direct investor | Private equity | Growth – Buyout | San Diego, United States |
| Rubicon Healthcare Partners AS life science tools · outsourced pharma services · manufacturing and enabling technologies · biologics |
Direct investor | Private equity | Growth | Fornebu, Norway |